Prostate Cancer - Results from #1020

Beyond the Abstract - The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: Magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans, by Katja Langen, PhD September 19, 2012

Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer, "Beyond the Abstract," by Giorgio Arcangeli, MD and Stefano Arcangeli, MD September 18, 2012

Implanted dosimeters identify radiation overdoses during IMRT for prostate cancer, "Beyond the Abstract," by Nicholas G. Zaorsky, MD and Robert B. Den, MD September 13, 2012

Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis, "Beyond the Abstract," by Fazlul H. Sarkar, PhD, et al September 11, 2012

Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM, "Beyond the Abstract," by Fazlul H. Sarkar, PhD, et al September 11, 2012

Predicting prostate biopsy outcome: Prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers, "Beyond the Abstract," by Matteo Ferro, Dario Bruzzese, Sisto Perdonà, Claudia Mazzarella and Daniela Terracciano September 5, 2012

The influence of distress on knowledge transfer for men newly diagnosed with prostate cancer, "Beyond the Abstract," by Richard Hovey, PhD August 31, 2012

Shear wave ultrasound elastography of the prostate: Initial results, "Beyond the Abstract," by Richard Memo, MD, FACS and Richard G. Barr, MD, PhD, FAC August 29, 2012

Variations of serum testosterone levels in prostate cancer patients under luteinizing hormone-releasing hormone therapy: An open question, "Beyond the Abstract," by Leonardo Oliveira Reis, MD, MSc, PhD August 27, 2012

Beyond the Abstract - Is sampling transitional zone in patients who had prior negative prostate biopsy necessary? by Ege Can Serefoglu, MD, et al August 23, 2012

Beyond the Abstract - Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer, by Michael Fisch, MD, MPH, FACP, FAAHPM August 22, 2012

Beyond the Abstract - N-acetyltransferase-2 gene polymorphisms and prostate cancer susceptibility in Latin American patients, by Leonardo Oliveira Reis, MD, MSc, PhD August 22, 2012

Beyond the Abstract - Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy, by Theo Van der Kwast, Najla Al Daoud, and Robert G. Bristow August 17, 2012

Beyond the Abstract - Development of novel immune interventions for prostate cancer, by Neeraj Agarwal and Nicholas J. Vogelzang August 15, 2012

Beyond the Abstract - PCA: Prostate cancer, patient-centred approach or both? by Louis Denis, Steven Joniau, Alberto Bossi, Edwina Baskin-Bey, and John M. Fitzpatrick August 14, 2012

Beyond the Abstract - Androgen regulation of 5α-reductase isoenzymes in prostate cancer: Implications for prostate cancer prevention, by Jin Li, PhD, Christopher I. Amos, PhD, and Jeri Kim, MD August 14, 2012

Beyond the Abstract - Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): A new risk factor for prostate cancer, by Bimal Bhindi August 10, 2012

Beyond the Abstract - Distinct redox profiles of selected human prostate carcinoma cell lines: Implications for rational design of redox therapy, by Luksana Chaiswing, PhD August 9, 2012

Beyond the Abstract - Patients aged more than 70 had higher risk of locally advanced prostate cancers and biochemical recurrence in Korea, by Jung Kwon Kim and Sung Yong Cho August 7, 2012

Beyond the Abstract - In vivo versus in vitro individual radiosensitivity analysed in healthy donors and in prostate cancer patients with and without severe side effects after radiotherapy, by Michael Pinkawa, MD, PhD August 6, 2012

Page 52 of 58